Martek/Abbott exclusive supply deal
This article was originally published in The Tan Sheet
Martek Biosciences will serve as exclusive worldwide supplier of DHA and ARA for Abbott Nutrition's infant formula products, including Similac Advance, under a new, long-term supply agreement announced Oct. 8. Abbott signed a 25-year, non-exclusive supply agreement with Martek in 2000 that will remain in effect (1"The Tan Sheet" Sept. 29, 2003, p. 14). The new deal provides for a 10-year term, though Abbott can terminate as of January 2012. Martek's life'sDHA and life'sARA ingredients are used in more than 95% of U.S. infant formulas...
You may also be interested in...
Martek Biosciences is working toward substantially lowering the cost of making docosahexaenoic acid (DHA) through a business venture with a genetics seed company
ABHI’s Phil Brown believes the future of UK device regulation will be innovation-friendly and patient-responsive system – but doesn’t expect easy alignment with the EU. See what he had to say.
Biologics license application is preferred route to market, but if emergency authorization is given it should happen with full transparency and be communicated in a clear manner to strengthen public confidence, National Vaccine Advisory Committee says.